Cargando…
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients
BACKGROUND: The p.E318K variant of the Melanocyte Inducing Transcription Factor (MITF) has been implicated in genetic predisposition to melanoma as an intermediate penetrance allele. However, the impact of this variant on clinico-phenotypic, as well as on dermoscopic patterns features of affected pa...
Autores principales: | Ciccarese, Giulia, Dalmasso, Bruna, Bruno, William, Queirolo, Paola, Pastorino, Lorenza, Andreotti, Virginia, Spagnolo, Francesco, Tanda, Enrica, Ponti, Giovanni, Massone, Cesare, Drago, Francesco, Parodi, Aurora, Ghigliotti, Giovanni, Pizzichetta, Maria Antonietta, Ghiorzo, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017513/ https://www.ncbi.nlm.nih.gov/pubmed/32054529 http://dx.doi.org/10.1186/s12967-020-02253-8 |
Ejemplares similares
-
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
por: Vanni, Irene, et al.
Publicado: (2020) -
Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1
por: Pastorino, Lorenza, et al.
Publicado: (2020) -
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2017) -
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2018) -
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
por: Spagnolo, Francesco, et al.
Publicado: (2021)